Bio News. Sunday March 24, 2013 3SBio Inc. Ann
Post# of 63824
Posted On: 03/24/2013 10:31:08 AM
Bio News.
Sunday March 24, 2013
- 3SBio Inc. Announces Extraordinary General Meeting of Shareholders
10:10 am - PR Newswire - Veterinary Hospital in Portsmouth Makes Pet Wellness More Affordable
10:00 am - GlobeNewswire - Baltimore Pet Care Team Recommends Annual Veterinary Dental Cleanings
10:00 am - GlobeNewswire - Evogene Reports Fourth Quarter and Year End 2012 Financial Results
9:00 am - Marketwire - "Fountain of Youth" Pill SeroVital™-hgh Huge Draw at D.C. Women's Health Conference
3:09 am - PR Newswire
Saturday March 23, 2013
- Fortune Magazine Profiles ArcView Group, Co-founded by Steve DeAngelo
1:33 pm - PR Newswire - Becker's Spine Review Releases List of 50 Spine Surgeons & Specialists Researching Biologics for Spine Treatments
2:00 am - PR Newswire
Friday March 22, 2013
- FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US
8:54 pm - PR Newswire - CORRECTING and REPLACING FDA Approves GE Healthcare's AdreView™ (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients
7:07 pm - Business Wire - Hologic Announces Expiration of 6.25% Senior Notes Exchange Offer
5:59 pm - PR Newswire - Bio-pharma Internal Communications Groups Evolving for Structure Optimization
5:30 pm - PR Newswire - Research and Markets: Urinary Incontinence - Pipeline Review, H1 2013
4:58 pm - Business Wire - Research and Markets: Astrocytoma - Pipeline Review, H1 2013
4:53 pm - Business Wire - Research and Markets: 2013 US Respiratory Diseases: Market Outlook and Emerging Opportunities
4:46 pm - Business Wire - Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
4:31 pm - PR Newswire - Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Phase of the Interference
4:12 pm - GlobeNewswire - Research and Markets: Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013
4:12 pm - Business Wire - Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
4:08 pm - CNW Group - Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
4:07 pm - PR Newswire - Accellent Inc. Announces Timing of Fourth Quarter 2012 Earnings Release and Conference Call
4:05 pm - Business Wire - Hologic Completes Sale of LIFECODES to Immucor
4:01 pm - PR Newswire - The Cooper Companies Holds Annual Meeting of Stockholders
4:01 pm - GlobeNewswire - IBEX Announces Departure of its Director of Finance
4:00 pm - Marketwire - Walgreens Debuts New Flagship Store in the Iconic Empire State Building
4:00 pm - Business Wire - IBEX Announces Departure of its Director of Finance
4:00 pm - Marketwire
(0)
(0)